Autism: Pathophysiology and promising herbal remedies

Current Pharmaceutical Design

Volumn 22, Issue 3, 2016, Pages 277-285

  Bahmani, Mahmoud ^a   Sarrafchi, Amir ^b   Shirzad, Hedayatollah ^b   Rafieian Kopaei, Mahmoud ^b  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Autism; Children; Ginkgo biloba; Herbal medicines

Indexed keywords

AMINO ACID RECEPTOR AFFECTING AGENT; BIOLOGICAL FACTOR; GINKGO BILOBA EXTRACT; GLUCOCORTICOID; HERBACEOUS AGENT; OPIATE RECEPTOR; PLANT MEDICINAL PRODUCT;

ACORUS CALAMUS; ADRENERGIC SYSTEM; AGGRESSION; ARTICLE; AUTISM; AUTOMUTILATION; CALAMUS; CENTELLA ASIATICA; CHOLINERGIC SYSTEM; COMPULSION; DOPAMINERGIC SYSTEM; GENETICS; GINGER; GINKGO BILOBA; HERBAL MEDICINE; HUMAN; HYPERACTIVITY; IMMUNE SYSTEM; MEDICINAL PLANT; NEUROCHEMISTRY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SLEEP DISORDER; SOCIAL PSYCHOLOGY; STEREOTYPY; SYMPTOM; ANTISOCIAL PERSONALITY DISORDER; AUTISTIC DISORDER; BRAIN CHEMISTRY; CHEMISTRY; COGNITIVE DEFECT; DRUG DEVELOPMENT; DRUG EFFECTS; IMMUNOMODULATION; ISOLATION AND PURIFICATION; PROCEDURES; PSYCHOLOGY;

AUTISTIC DISORDER; BRAIN CHEMISTRY; COGNITION DISORDERS; DRUG DISCOVERY; HUMANS; NEUROIMMUNOMODULATION; PLANT PREPARATIONS; PLANTS, MEDICINAL; SOCIAL BEHAVIOR DISORDERS;

EID: 84962510841     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666151112151529     Document Type: Article

References (122)

1. Rapin I, Tuchman R. Autism: definition, neurobiology, screening, diagnosis. Pediatr Clin North Am 2008; 55(5): 1129-46.
2. Newschaffer C, Croen L, Daniels J, et al. The epidemiology of autism spectrum disorders. Annu Rev Public Health 2007; 28: 235-58.
3. National Dissemination Center for Children with Disabilities(NICHCY). Disability Info: Pervasive Developmental Disorders. Fact Sheet 20(FS20) October 2003.
4. Myers S, Johnson C. Management of children with autism spectrum disorders". Pediatrics 2007; 120(5): 1162-82.
5. Oswald D, Sonenklar N. Medication use among children with autism spectrum disorders. J Child Adolesc Psychopharmacol 2007; 17(3): 348-55.
6. Ganz M. The lifetime distribution of the incremental societal costs of autism. Arch Pediatr Adolesc Med 2007; 161(4): 343-9.
7. Saki K, Bahmani M, Rafieian-Kopaei M. The effect of most important medicinal plants on two important psychiatric disorders (anxiety and depression)-a review. Asian Pac J Trop Med 2014; 7(Suppl 1): 34-42.
8. Rabiei Z, Rafieian-kopaei M, Heidarian E, Saghaei E, Mokhtari S. Effects of Zizyphus jujube extract on memory and learning impairment induced by bilateral electric lesions of the nucleus basalis of meynert in rat. Neurochem Res 2014; 39(2): 353-60.
9. Delfan B, Bahmani M, Hassanzadazar H, Saki K, Rafieian-Kopaei M. Identification of medicinal plants affecting on headaches and migraines in Lorestan Province, West of Iran. Asian Pac J Trop Med 2014; 7(Suppl 1): 376-379.
10. Michael G, Paul H, Philip C. Shorter Oxford Textbook of psychiatry. 5th ed. Oxford University Press. New York 2006; pp: 671-8.
11. Glebenzon BJ, Rosenberg AL. On Autism: its prevalence, diagnosis, causes & treatment. Top Clin Chiropr 2001; 8: 42-57.
12. Happé F, Ronald A. The fractionable autism triad: a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychol Rev 2008; 18(4): 287-304.
13. Happé F, Ronald A, Plomin R. Time to give up on a single explanation for autism. Nat Neurosci 2006; 9(10): 1218-20.
14. Abrahams B, Geschwind D. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Gen 2008; 9(5): 341-55.
15. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics 2004; 113: e472-86.
16. Cheng Y, Qin G, Dai X, Zhao Y, NPY1. A BTB-NPH3-like protein plays a critical role in auxin-regulated organogenesis in Arabidopsis. Proc Natl Acad Sci 2007; 104: 18825-9.
17. Jamain S, Betancur C, Quach H, et al. Paris Autism Research International Sibpair(PARIS) Study. Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 2002; 7: 302-10.
18. Iacoboni M, Dapretto M. The mirror neuron system and the consequences of its dysfunction. Nat Rev Neurosci 2006; 7(12): 942-51.
19. Kenworthy L, Yerys B, Anthony L, Wallace G. Understanding executive control in autism spectrum disorders in the lab and in the real world. Neuropsychol Rev 2008; 18(4): 320-38.
20. Happé F, Frith U. The weak coherence account: detail-focused cognitive style in autism spectrum disorders. J Autism Dev Disord 2006; 36(1): 5-25.
21. Mottron L, Dawson M, Soulières I, Hubert B, Burack J. Enhanced perceptual functioning in autism: an update, and eight principles of autistic perception. J Autism Dev Disord 2006; 36(1): 27-43.
22. Rajendran G, Mitchell P. Cognitive theories of autism. Dev Rev 2007; 27(2): 224-60.
23. Sadok BJ, Sadok VA. Comprehensive textbook of psychiatry.8th ed. Philadelphia: Williams & Wilking 2005; pp. 3164-75.
24. Lam KSL, Aman MGL, Arnold E. Neurochemical correlates of autistic disorder: A review of the literature. Res Develop Disabil 2006; 27: 254-89.
25. Whitaker-Azimitia PM. Serotonin and brain development: Role in human developmental diseases. Brain Res Bull 2001; 56: 479-85.
26. Carlson NR. Physiology of behavior 7th ed. Boston: Allyn and Bacon 2001; pp. 96-129.
27. Adamsen D, Meili D, Blau N, Thony B, Ramaekers V. Autism associated with low 5-hydroxyindolacetic acid in CSF and the heterozygous SLC6A4 gene Gly56Ala plus 5-HTTLPR L/L promoter variants. Mol Genet Metab 2011; 102: 368-73.
28. Adamsen D, Ramaekers V, Ho H, et al. Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter(PMAT) gene. Autism Mol 2014; 5: 43.
29. Harrington RA, Lee LC, Crum RM, Zimmerman AW, Hertz P. Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy. Autism Res 2013; 6(3): 149-68.
30. Campbell HL, Tivarus ME, Hillier A, Beversdorf DQ. Increased task difficulty results in greater impact of noradrenergic modulation of cognitive flexibility. Pharmacol Biochem Behav 2008; 88: 222-9.
31. Zhang, Sun Y, Wang F, Wang Z, Peng Y, Li R. Downregulating the canonical Wnt/ß-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress. Neurochem Res 2012; 37: 1409-19.
32. Luong KVQ, Nguyễn LTH. The role of beta-adrenergic receptor blockers in autism. Am J Psychiatr Neurosci 2013; 1(1): 14-21.
33. Baradaran A, Rabiei Z, Rafieian M, Shirzad H. A review study on medicinal plants affecting amnesia through cholinergic system. J Herbmed Plarmacol 2012; 1(1): 3-9.
34. Rahnama S, Rabiei Z, Alibabaei Z, Mokhtari S, Rafieian-kopaei M, Deris F. Anti-amnesic activity of Citrus aurantium flowers extract against scopolamine-induced memory impairments in rats. Neurological Science 2014: 1-8.
35. Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 2006; 27: 254-89.
36. Polleux F, Lauder JM. Toward a developmental neurobiology of autism. Ment Retard Dev Disabil Res Rev 2004; 10: 303-17.
37. Rafieian-Kopaei M, Gray AM, Spencer PS, Sewell RDE. Contrasting actions of acute or chronic paroxetine and fluvoxamine on morphine withdrawal-induced place conditioning. Eur J Pharmacol 1995; 6; 275(2): 185-9.
38. Ghaleiha A, Ghyasvand G, Mohammadi MR, et al. Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial. J Psychopharmacol 2014; 28(7): 677-685.
39. Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M. Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants. Curr Pharm Des 2015; [Epub ahead of print].
40. Bahmani M, Shirzad HA, Majlesi M, Shahinfard N, Rafieian- Kopaei M. A review study on analgesic applications of Iranian medicinal plants. Asian Pacific J Trop Med 2014; 7(Suppl 1): 43-53.
41. Doyle CA, McDougle CJ. Dopamine. Encyclopedia Autism Spect Disord 2013; 988-4.
42. Masi G, Cosenza A, Mucci M, De Vito G. Risperidone monotherapy in preschool children with pervasive developmental disorders. J Child Neurol 2001; 16: 395-400.
43. Hunter LC, O'Hare A, Herron WJ, Fisher LA, Jones GE. Opioid peptides and dipeptidyl peptidase in autism. Dev Med Child Neurol 2003; 45(2): 121-8.
44. Shirzad H, Shahrani M, Rafieian-Kopaei M. Comparison of morphine and tramadol effects on phagocytic activity of mice peritoneal phagocytes in vivo. Int Immunopharmacol 2009; 9(7-8): 968-70.
45. Polleux F, Lauder JM. Toward a developmental neurobiology of autism. Ment Retard Dev Disabil Res Rev 2004; 10: 303-17.
46. Duffy FH, Shankardass A, McAnulty GB, et al. Corticosteroid therapy in regressive autism: a retrospective study of effects on the Frequency Modulated Auditory Evoked Response(FMAER), language, and behaviour. BMC Neurol 2014; 14: 70.
47. Manent JB, Represa A. Neurotransmitters and brain maturation: early paracrine actions of GABA and glutamate modulate neuronal migration. Neuroscientist 2007; 13: 268-79.
48. Barnby G, Abbott A, Sykes N, et al. Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association atGRIN2A and ABAT. Am J Hum Genet 2005; 76: 950-66.
49. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 2001; 57: 1618-8.
50. Derkach VA, Oh MC, Guire ES, Soderling TR. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev 2007; 8: 101-13.
51. Manent JB, Represa A. Neurotransmitters and brain maturation: early paracrine actions of GABA and glutamate modulate neuronal migration. Neuroscientist 2007; 13: 268-79.
52. Evitt P, Eagleson KL, Powell EM. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 2004; 27: 400-6.
53. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 2001; 57(9): 1618-28.
54. Kornhuber J, Mack-Burhardt F, Konradi C, Fritze J, Riderer P. Effect of antemortem and postmortem factors on [3H]MK-801 binding in the human brain: Transient elevation during early childhood. Life Science 1999; 45: 745-9.
55. Hussman JP. Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J Autism Develop Disord 2001; 31: 247-8.
56. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR. Glutamic acid decarboxylase 65 & 67 kDa proteins are reduced in autistic parietal & cerebellar cortices. Biol Psychiatry 2002; 52: 805-10.
57. Kaplan HI, Sadok BJ. Synopsis of psychiatry. 10th ed. Lippincott. Philadelphia: Williams and Wilkins 2007; pp. 1208-22.
58. Glebenzon BJ, Rosenberg AL. On Autism: its prevalence, diagnosis, causes & treatment. Top Clin Chiropr 2001; 8: 42-57.
59. Gudarzi SS, Yasamy M, Akhondzadeh S. Cyproheptadine in treatment of autism. Eur Psychiatry 2002; 17(4): 230-1.
60. Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications. Drugs 2005; 65: 1493-520.
61. Matson JL, Beighley J, Turygin N. Autism diagnosis and screening: Factors to consider in differential diagnosis. Res Autism Spectr Disord 2012; 6(1): 19-24.
62. Silva LMT, Schalock M, Ayres R. A model and treatment for autism at the convergence of Chinese medicine and Western science: First 130 cases. Chinese J Integr Med 2011 17(6): 421-9.
63. Buitelaar JK, Willemsen-Swinkels SH. Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy. Paediatr Drugs 2000; 2: 67-8.
64. Malone RP, Cater J, Sheikh RM, Choudhury MS, Delaney MA. Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. J Am Acad Child Adolesc Psychiatry 2001; 40: 887-94.
65. Akhondzadeh S, Fallah J, Mohammadi MR, et al. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism. Prog Neuropsychopharmacol. Biol Psychiatry 2010; 34: 32-6.
66. Handen BL, Johnson CR, Lubetsky M. Efficacy of methylphenidate among children with autism and symptoms of attentiondeficithyperactivity disorder. J Autism De Disord 2000; 30: 245-55.
67. Akhondzadeh S, Tajdar H, Mohammadi MR, et al. A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder. Child Psychiatry Hum Dev 2008; 39: 237-45.
68. Rezaei V, Mohammadi MR, Ghanizadeh A, et al. Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34(7): 1269-72.
69. Rabiei Z, Rafieian M. Effects of Zizyphus jujuba extract on motor coordination impairment induced by bilateral electric lesions of the nucleus basalis of meynert in rat. Physiol Pharmacol 2014; 17(4): 469-77.
70. Delfan B, Bahmani M, Rafieian-Kopaei M, Delfan M, Saki K. A review study on ethnobotanical study of medicinal plants used in relief of toothache in Lorestan province, Iran. Asian Pacific J Trop Dis 2014; 4(Suppl 2): 879-84.
71. Roohafza H, Sarrafzadegan N, Sadeghi M, Rafieian-Kopaei M, Sajjadi F, Khosravi-Boroujeni H. The association between stress levels and food consumption among Iranian population. Arch Iran Med 2013; 16(3): 145-8.
72. Asgary S, Sahebkar A, Afshani, M, Keshvari M. Haghjooyjavanmard, Sh, Rafieian-Kopaei M. Clinical evaluation of blood pressure inflammatory effects of pomegranate juice in hypertensive subjects. Phytother Res 2014; 28(2): 193-9.
73. Rafieian-Kopaei M, Shahinfard, N, Rouhi-Boroujeni H, Gharipour M, Darvishzadeh-Boroujeni P. Effects of Ferulago angulata extract on serum lipids and lipid peroxidation. Evid Based Complement Alternat Med 2014; 2014: 680856.
74. Sarrafzadegan N, Khosravi-Boroujeni H, Esmaillzadeh A, Sadeghi M, Rafieian-Kopaei M, Asgary S. The association between hypertriglyceridemic waist phenotype, menopause, and cardiovascular risk factors. Arch Iran Med 2013; 16(3): 161-6.
75. Bahmani M, Zargaran, A, Rafieian-Kopaei M, Saki M. Ethnobotanical study of medicinal plants used in the management of diabetes mellitus in the Urmia, Northwest Iran. Asian Pacific J Trop Med 2014; 7(Suppl 1): 348-54.
76. Mirhoseini M, Baradaran A, Rafieian-Kopaei M. Medicinal plants, diabetes mellitus and urgent needs. J Herbmed Pharmacol 2013; 2(2): 53-4.
77. Asgary S, Rafieian-Kopaei M, Shamsi F, Najafi S, Sahebkar A. Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of cornelian cherry(Cornus mas L.) in alloxan-induced diabetic rats. J Complement Integr Med 2014; 11(2): 63-9.
78. Baradaran A, Nasri H, Nematbakhsh M, Rafieian-Kopaei M. Antioxidant activity and preventive effect of aqueous leaf extract of Aloe vera on gentamicin-induced nephrotoxicity in male Wistar rats. Clin Ther 2014; 165(1): 7-11.
79. Nasri H, Rafieian-Kopaei M. Tubular kidney protection by antioxidants. Iranian J Publ Health 2013; 42(10): 1194-6.
80. Ghaed F, Rafieian-Kopaei M, Nematbakhsh M, Baradaran A, Nasri H. Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J Res Med Sci 2012; 17(7): 621-5.
81. Nasri H, Shirzad H. Toxicity and safety of medicinal plants. J Herbmed Plarmacol 2013; 2(2): 21-2.
82. Werneke U, Turner T, Priebe S. Complementary medicines in psychiatry: review of effectiveness and safety. Br J Psychiatry 2006; 188: 109-21.
83. Smith TC, Ryan MA, Smith B, et al. Complementary and alternative medicine use among US Navy and Marine Corps personnel. BMC Complement Altern Med 2007; 7: 16.
84. Noorbala AA, Akhondzadeh S. Attention deficit/hyperactivity disorder: etiology and pharmacotherapy. Arch Iran Med 2006; 9: 374-80.
85. Hechtman L. Attention -deficit/Hyperactivity disorder. In: Sadock BJ, Sadock VA. Eds. Comprehensive text book of psychiatry. 8th ed. Philadelphia: Lippincott Williams & Wilkins 2005.
86. Huguet F, Drieu K, Piriou A. Decreased cerebral 5-HT1A receptors during ageing: Reversal by Ginkgo biloba extracts(EGb 761). J Pharm Pharmacol 1994; 46: 316-8.
87. White HL, Scates PW, Cooper BR. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 1996; 58: 1315-21.
88. Burns NR, Bryan J, Nettelbeck T. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults. Hum Psychopharmacol 2006; 21: 27-37.
89. Wang YS, Xu L, Ma K, Wang S, Wang JJ. Protective effects of Ginkgo biloba extract against glutamate-induced neurotoxicity in cultured retinal neuron. Chin Med J(Engl) 2005; 118: 948-52.
90. Sierpina VS, Wollschlaeger B, Blumenthal M. Ginkgo biloba. Am Fam Physician 2003; 68: 923-6.
91. Chan E. The role of complementary and alternative medicine in attention-deficit hyperactivity disorder. J Dev Behav Pediatr 2002; 23: S37-45.
92. Hasanzadeh E, Mohammadi MR, Ghanizadeh A, et al. A doubleblind placebo controlled trial of ginkgo biloba added to risperidone in patients with autistic disorders. Child Psychiatry Hum Dev 2012; 43(5): 674-82.
93. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth 2000; 84(3): 367-71.
94. Rasool M, Malik A, Qureshi MS, et al. Recent updates in the treatment of neurodegenerative disorders using natural compounds. Evid-Based Complement Alternat Med 2014 (2014): 979730.
95. Bedir E, Pugh N, Calis I, Pasco DS, Khan IA. Immunostimulatory effects of cycloartane-type triterpene glycosides from astragalus species. Biol Pharm Bull 2000; 23(7): 834-7.
96. Zheng Z, Liu D, Song C, Cheng C, Hu Z. Studies on chemical constituents and immunological function activity of hairy root of Astragalus Chin J Biotechnol 1998; 14(2): 93-7.
97. Chen YJ, Dai YS, Chen BF, et al. The effect of tetrandrine and extracts of Centella asiatica on acute radiation dermatitis in rats. Biol Pharm Bull 1999; 22(7): 703-6.
98. Shukla A, Rasik AM, Jain GK, Shankar R, Kulshrestha DK, Dhawan BN. In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. J Ethnopharmacol 1999; 65(1): 1-11.
99. Mook-Jung I, Shin JE, Yun SMH, et al. Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity. J Neurosci Res 1999; 1; 58(3): 417-25.
100. Veerendra-Kumar MH, Gupta YK. Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer’s disease in rats. Clin Exp Pharmacol Physiol 2003; 30(5-6): 336-42.
101. Dhawan D. In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. J Ethnopharmacol 1999; 65(1): 1-11.
102. Balakumbahan R, Rajamani K, Kumanan K. Acorus calamus: An overview. J Med Plants Res 2011; 4(25): 2740-5.
103. Srikantha-Murthy KR. Vagbhata’s Astanga Hrdayam. vol. 3. Varanasi: Krishnadas Academy 1995; p. 387.
104. Bahmani M, Rafieian M, Baradaran A, Rafieian S, Rafieian-Kopaei M. Nephrotoxicity and hepatotoxicity evaluation of Crocus sativus stigmas in neonates of nursing mice. J Nephropathol 2014; 3(2): 81-5.
105. Madihi Y, Merrikhi A, Baradaran A, et al. Impact of Sumac on postprandial high-fat oxidative stress. Pak J Med Sci 2013; 29(1): 340-5.
106. Hasanpour Z, Nasri H, Rafieian-Kopaei M, Ahmadi A, Baradaran A, Nasri P, Nematbakhsh M. Paradoxical effects of atorvastatin on renal tubular cells: an experimental investigation. Iran J Kidney Dis 2015; 9(3): 215-20.
107. Baradaran A, Nasri H, Rafieian-Kopaei M. Protection of renal tubular cells by antioxidants: Current knowledge and new trends. Cell J (Yakhteh), Winter 2015; 16(4): 568-568.
108. Rabiei Z., Rafieian-Kopaei M, Mokhtari S, Alibabaei Z, Shahrani M. The effect of pretreatment with different doses of Lavandula officinalis ethanolic extract on memory, learning and nociception. Biomed Aging Pathol 2014; 4(1): 71-6.
109. Rafieian-Kopaei M, Nasri H. Comment on: preventive effect of Teucrium polium on learning and memory deficits in diabetic rats. Med Sci Monit Basic Res. 2013; 19: 208-9.
110. Alibabaei Z, Rabiei Z, Rahnama S, Mokhtari S, Rafieian-kopaei M. Matricaria Chamomilla extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Biomed Aging Pathol 4(2014) 355-60.
111. Delfan B, Bahmani M, Rafieian-Kopaei M, Delfan M, Saki K. A review study on ethnobotanical study of medicinal plants used in relief of toothache in Lorestan province, Iran. Asian Pacific J Trop Dis 2014; 4(Suppl 2): S879-S884.
112. Rafieian-Kopaei M, Nasri H. Comment on: preventive effect of Teucrium polium on learning and memory deficits in diabetic rats. Med Sci Monit Basic Res 2013; 19: 208-9.
113. Saki K, Bahmani M, Rafieian-Kopaei M, Hassanzadazar H, Dehghan K, Bahmani F, Asadzadeh J. The most common native medicinal plants used for psychiatric and neurological disorders in Urmia city, northwest of Iran. Asian Pacific J Trop Dis 2014; 4(2): S895-S901.
114. Saki K, Bahmani M, Rafieian-Kopaei M. The effect of most important medicinal plants on two importnt psychiatric disorders(anxiety and depression)-a review. Asian Pacific J Trop Med 2014; 7S1: S34-42.
115. Delfan B, Bahmani M, Hassanzadazar H, Saki K, Rafieian-Kopaei M. Identification of medicinal plants affecting on headaches and migraines in Lorestan province, West of Iran. Asian Pacific J Trop Med 2014; 7S1: S376-9.
116. Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology 2006; 13(3): 171-81.
117. Ghanizadeh A, Akhondzadeh S, Hormozi M, Makarem A, Abotorabi-Zarchi M, Firoozabadi A. Glutathione-related factors and oxidative stress in autism, a review. Curr Med Chem 2012; 19(23): 4000-5.
118. Bahmani M, Rafieian-Kopaei M, Hassanzadazar H, Saki K, Karamati SA, Delfan B. A review on most important herbal and synthetic antihelmintic drugs. Asian Pacific J Trop Med 2014; 7S1: S29-33.
119. Akhlaghi M, Shabanian G, Rafieian-Kopaei M, Parvin N, Saadat M, Akhlaghi M. Citrus aurantium blossom and preoperative anxiety. Rev Bras Anestesiol 2011; 61(6): 702-12.
120. Bahmani M, Rafieian-Kopaei M, Jeloudari M, et al. A review of the health effects and uses of drugs of plant licorice(Glycyrrhiza glabra L.) in Iran. Asian Pacific J Trop Dis 2014; 4(2): S847-S9.
121. Sharafati-Chaleshtori R, Rokni N, Rafieian-Kopaei M, Drees F, Sharafati-chaleshtori A and Salehi E. Use of Tarragon(Artemisia dracunculus) essential oil as a natural preservative in beef burger. Ital J Food Sci 2014; 26: 427-32.
122. Bahmani M, Rafieian-Kopaei M, Karamati A, Bahmani F, Bahmani F, Bahmani E, Asadzadeh J. Antiparasitic herbs used in west regions of Ilam province located in west of Iran. Asian Pac J Trop Dis 2014; 4(2): S764-S9.